Barclays PLC

BCY.DE·XETRA·Financial Services
Compare
4.9855−0.1465 (−2.85%)today
As of Oct 19, 12:31 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.1320
Open5.0650
Day range4.98555.0680
52-week range4.15006.2960
Off day high−1.63%
Off 52-week high−20.81%
Volume37.17K
Avg. volume (3M)101.36K
Market cap66.46B
EPS (TTM)0.5600
Forward P/E—
P/E ratio (TTM)8.90
Dividend yield2.60% (0.1300)
Beta (5Y)0.91
Shares outstanding13.33B
Short interest—
Earnings dateOct 22, 2026
Analyst target—
Profit margin27.87%

Against its peers

Compare in full ›
BCY.DE HSBC NA.TO SAN CM WBC.F
Market cap 66.46B 323.43B 78.18B 192.28B 102.12B 74.65B
P/E (TTM) 8.9 13.5 17.1 12.9 15.0 18.8
Forward P/E — 9.9 14.2 9.3 14.0 —
Price/book 0.9 7.5 2.4 1.6 2.2 1.7
Dividend yield 2.60% 3.97% 2.59% 2.09% 2.68% 4.33%
1-year change +22.78% +44.01% +33.92% +34.75% +39.31% −0.58%
Today −2.85% +0.03% −0.06% −1.19% +0.20% +1.18%

The closest companies by business and industry (Banks - Diversified). Prices may be delayed up to 15 min.

Latest news

All BCY.DE news ›
The Globe and Mail·Positive

Fastenal Company (FAST) Gets a Hold from Barclays

Barclays analyst Guy Hardwick maintained a Hold rating on Fastenal Company today and set a price target of $46.00. According to TipRanks, Hardwick is a 5-star analyst with an average return of 16.5% and a 72.22% success rate. Hardwick…

The Globe and Mail·Negative

Barclays Remains a Hold on HCA Healthcare (HCA)

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on HCA Healthcare, with a price target of $387.00. Mok CFA covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Addus…

The Globe and Mail·Negative

Barclays Remains a Buy on Marsh & McLennan Companies (MRSH)

Barclays analyst Alex Scott maintained a Buy rating on Marsh & McLennan Companies today and set a price target of $206.00. According to TipRanks, Scott is a 5-star analyst with an average return of 8.1% and a 60.31% success rate. Scott…

markets.businessinsider.com·Negative

Legend Biotech (LEGN) Gets a Buy from Barclays

Barclays analyst Etzer Darout maintained a Buy rating on Legend Biotech today and set a price target of $68.00. Darout covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Summit Therapeutics, and AnaptysBio.…

markets.businessinsider.com·Negative

Barclays Keeps Their Buy Rating on Datadog (DDOG)

Barclays analyst Raimo Lenschow maintained a Buy rating on Datadog today and set a price target of $300.00. Lenschow covers the Technology sector, focusing on stocks such as Salesforce, HubSpot, and Atlassian. According to TipRanks,…

markets.businessinsider.com·

Collegium Pharmaceutical (COLL) Receives a Buy from Barclays

Barclays analyst Jenna Davidner maintained a Buy rating on Collegium Pharmaceutical today and set a price target of $48.00. Davidner covers the Healthcare sector, focusing on stocks such as Collegium Pharmaceutical, Xeris Pharmaceuticals,…

markets.businessinsider.com·Positive

Legend Biotech price target lowered to $68 from $74 at Barclays

Barclays lowered the firm’s price target on Legend Biotech (LEGN) to $68 from $74 and keeps an Overweight rating on the shares. The firm adjuste... Legend Biotech price target lowered to $68 from $74 at Barclays Barclays lowered the firm’s…

markets.businessinsider.com·Positive

Barclays Keeps Their Buy Rating on Fervo Energy Company Class A (FRVO)

Barclays analyst David Anderson maintained a Buy rating on Fervo Energy Company Class A today and set a price target of $48.00. According to TipRanks, Anderson is a 4-star analyst with an average return of 7.3% and a 51.30% success rate.…

markets.businessinsider.com·Positive

Datadog price target raised to $300 from $290 at Barclays

Barclays raised the firm’s price target on Datadog (DDOG) to $300 from $290 and keeps an Overweight rating on the shares. The firm adjusted targ... Datadog price target raised to $300 from $290 at Barclays Barclays raised the firm’s price…

StreetInsider.com·Negative

Cummins (CMI) PT Lowered to $675 at Barclays

Barclays analyst Adam Seiden lowered the price target on Cummins (NYSE: CMI) to $675.00 (from $760.00) while maintaining a Overweight rating. StreetInsider.com Top Tickers, 10/19/2026 - Wall Street tumbles as worries about AI trade and…

From articles in the 4Search news index.

In the news

811mentions in 30 days
811with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.